These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12730354)
1. Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects. Bart G; Borg L; Schluger JH; Green M; Ho A; Kreek MJ J Pharmacol Exp Ther; 2003 Aug; 306(2):581-7. PubMed ID: 12730354 [TBL] [Abstract][Full Text] [Related]
2. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779 [TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression. Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341 [TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. Schluger JH; Bart G; Green M; Ho A; Kreek MJ Neuropsychopharmacology; 2003 May; 28(5):985-94. PubMed ID: 12700714 [TBL] [Abstract][Full Text] [Related]
5. Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. Foltin RW; Christiansen I; Levin FR; Fischman MW J Pharmacol Exp Ther; 1995 Oct; 275(1):38-47. PubMed ID: 7562574 [TBL] [Abstract][Full Text] [Related]
6. Dynorphin modulates prolactin secretion in the turkey. Youngren OM; Silsby JL; Phillips RE; el Halawani ME Gen Comp Endocrinol; 1993 Aug; 91(2):224-31. PubMed ID: 8104840 [TBL] [Abstract][Full Text] [Related]
7. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain. Martin TJ; Kahn WR; Xiao R; Childers SR Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089 [TBL] [Abstract][Full Text] [Related]
8. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts. Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442 [TBL] [Abstract][Full Text] [Related]
9. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397 [TBL] [Abstract][Full Text] [Related]
10. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528 [TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients. Hay JL; White JM; Bochner F; Somogyi AA Eur J Pain; 2008 Oct; 12(7):926-33. PubMed ID: 18262451 [TBL] [Abstract][Full Text] [Related]
12. Human pharmacology of the opioid neuropeptide dynorphin A(1-13). Greenwald MK; Stitzer ML; Haberny KA J Pharmacol Exp Ther; 1997 Jun; 281(3):1154-63. PubMed ID: 9190848 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects. Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901 [TBL] [Abstract][Full Text] [Related]
14. Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study. Nava F; Manzato E; Leonardi C; Lucchini A Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1867-72. PubMed ID: 18801404 [TBL] [Abstract][Full Text] [Related]
15. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy. Chen TJ; Blum K; Payte JT; Schoolfield J; Hopper D; Stanford M; Braverman ER Med Hypotheses; 2004; 63(3):538-48. PubMed ID: 15288384 [TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors in human peripheral blood lymphocytes: changes in mRNA expression in opioid addiction. Goodarzi A; Vousooghi N; Sedaghati M; Mokri A; Zarrindast MR Eur J Pharmacol; 2009 Aug; 615(1-3):218-22. PubMed ID: 19445922 [TBL] [Abstract][Full Text] [Related]
17. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211 [TBL] [Abstract][Full Text] [Related]
18. [Serum leptin levels in patients with heroin addiction, the effect of one year of methadone substitution]. Wilczek H; Haluzík M; Svobodová J; Parízková J Vnitr Lek; 2004 Apr; 50(4):282-5. PubMed ID: 15214298 [TBL] [Abstract][Full Text] [Related]
19. A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Marinelli PW; Lam M; Bai L; Quirion R; Gianoulakis C Alcohol Clin Exp Res; 2006 Jun; 30(6):982-90. PubMed ID: 16737456 [TBL] [Abstract][Full Text] [Related]
20. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users. Bloor M; McIntosh J; McKeganey N; Robertson M Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]